Patents by Inventor John Eldon Toth

John Eldon Toth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mixed lineage kinase modulators
    Patent number: 7511065
    Abstract: The present invention provides a compound of the formula: (Formula I); or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: March 31, 2009
    Assignee: Eli Lilly and Company
    Inventors: Theodore Goodson, Jr., Mary Margaret Mader, John Eldon Toth, Arindam Chatterjee, Jason Scott Sawyer
  • Mixed Lineage Kinase Modulators
    Publication number: 20080113977
    Abstract: The present invention provides a compound of the formula: (Formula I); or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 15, 2008
    Inventors: Arindam Chatterjee, Theodore Goodson Jr, Mary Margaret Mader, John Eldon Toth
  • Antithrombotic agents
    Patent number: 6620837
    Abstract: This application relates to novel compounds of formula (I) (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of defined compounds of formula (I) as thrombin inhibitors.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: September 16, 2003
    Assignee: Eli Lilly and Company
    Inventors: Daniel Jon Sall, John Eldon Toth, Kumiko Takeuchi, Todd Johnathan Kohn, Jolie Anne Bastian
  • Antithrombotic agents
    Patent number: 6133262
    Abstract: This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of the compounds of formula I as thrombin inhibitors.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: October 17, 2000
    Assignee: Eli Lilly and Company
    Inventors: Jefferson Ray McCowan, John Eldon Toth, Daniel Jon Sall